VPTDF (VentriPoint Diagnostics) Stock Based Compensation: $0.51 Mil (TTM As of Dec. 2025)


VPTDF VentriPoint Diagnostics Ltd VPTDF
10 GF Score
Price $0.08
! 4 Warning Signs
View Full Analysis

What is VentriPoint Diagnostics Stock Based Compensation?

VentriPoint Diagnostics VPTDF -4.66% 10 Stock Based Compensation is $0.51 Mil as of Dec. 2025. GuruFocus rates VPTDF with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

VentriPoint Diagnostics's Stock Based Compensation for the three months ended in Dec. 2025 was $0.13 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was $0.51 Mil.

VentriPoint Diagnostics Stock Based Compensation Related Terms

VentriPoint Diagnostics Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics Stock Based Compensation Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.59 0.37 0.48 0.52

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.10 0.26 0.02 0.13
VPTDF
10GF Score
VentriPoint Diagnostics Ltd VPTDF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VentriPoint Diagnostics Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.51 Mil.

What does a Stock Based Compensation of $0.51 Mil mean?
VentriPoint Diagnostics (VPTDF) has a Stock Based Compensation of $0.51 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for VentriPoint Diagnostics and its competitors.
Is VentriPoint Diagnostics' Stock Based Compensation too high?
VentriPoint Diagnostics' current Stock Based Compensation is $0.51 Mil. Overall, VentriPoint Diagnostics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does VentriPoint Diagnostics' Stock Based Compensation compare to ABT and SYK?
VentriPoint Diagnostics' Stock Based Compensation of $0.51 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for VentriPoint Diagnostics and its competitors. VentriPoint Diagnostics's current Stock Based Compensation is $0.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VentriPoint Diagnostics stock overvalued right now?
VentriPoint Diagnostics (VPTDF) has a current Stock Based Compensation of $0.51 Mil. The current Stock Based Compensation is $0.51 Mil. VentriPoint Diagnostics' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current Stock Based Compensation is $0.51 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VentriPoint Diagnostics Business Description

Other Exchanges VPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
10GF Score

Get the complete analysis for VPTDF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price